TECH OFFER

TaqMan genotyping assays for Malaysian Chinese Beta thalassaemia mutations

TECHNOLOGY OVERVIEW

The present invention discloses a rapid, sensitive and cost-effective in-house TaqMan 5 genotyping assay for the screening of common thalassemia mutations in Malaysian Chinese. The present invention comprises of four sets of forward and reverse primers for DNA amplification of the four common thalassemia mutations in Malaysian Chinese and four sets of normal and mutant probes. The probes were designed with minor groove binder (MGB) and non-fluorescent quencher (NFQ) at the 3' end, 10 whereas the 5' end contains fluorescence reporter dyes selected from the group of 2-chloro-7-phenyl-1,4-dichloro-6-carboxyfluorescein (VIC), 6-carboxyfluorescein (FAM) or the like.

Mega - Trends

Healthcare

Technology Readiness Level (TRL)

TRL 9

Patent Number

PI 2014700394

Get the technology fact sheet here:

Contact person for this offer:

ChM Dr. Lee Ching Shya, PhD (Dual), RTTP

Technology Transfer Manager

Email: leecs@um.edu.my

Tel: +603-7967-7351/ 013-2250151

MAKE AN ENQUIRY

press to zoom

press to zoom
1/1

MORE INFORMATION

You have a question to know about technologies or cooperations? 
Please Contact Us:

+603 - 7967 7351 / 013-2250151